G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochimica et biophysica acta. Molecular cell research

• Publication date

  2017-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbamcr.2017.05.001PMID 28476646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal Orphan G-Protein Coupled Receptor Proteins Mediate Plasmalogens-Induced Activation of ERK and Akt Signaling

  2016cited by this paper
• Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19.

  2016cited by this paper
• Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway

  2016cited by this paper
• Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy

  2016cited by this paper
• Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK

  2016cited by this paper
• GPCR Signaling Mediates Tumor Metastasis via PI3Kβ.

  2016cited by this paper
• Differential Responses of Plasma Adropin Concentrations To Dietary Glucose or Fructose Consumption In Humans

  2015cited by this paper
• Lung Epithelial Cells Induce Both Phenotype Alteration and Senescence in Breast Cancer Cells

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance

  2015cited by this paper
• Hunting for the function of orphan GPCRs – beyond the search for the endogenous ligand

  2015cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• Comparative Expression Study of the Endo–G Protein Coupled Receptor (GPCR) Repertoire in Human Glioblastoma Cancer Stem-like Cells, U87-MG Cells and Non Malignant Cells of Neural Origin Unveils New Potential Therapeutic Targets

  2014cited by this paper
• G-protein–coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion

  2014cited by this paper
• Sphingosine 1-Phosphate Receptors Are Essential Mediators of Eyelid Closure during Embryonic Development*

  2013cited by this paper
• The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism

  2013cited by this paper
• Regulatory networks defining EMT during cancer initiation and progression

  2013cited by this paper
• On the origin of cancer metastasis.

  2013cited by this paper
• GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.

  2013cited by this paper
• TGFα shedding assay: an accurate and versatile method for detecting GPCR activation

  2012cited by this paper
• In Vitro and In Vivo Antagonism of a G Protein-Coupled Receptor (S1P3) with a Novel Blocking Monoclonal Antibody

  2012cited by this paper
• EMT and MET as paradigms for cell fate switching.

  2012cited by this paper
• Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2–M Cell-Cycle Progression

  2012cited by this paper
• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  2012cited by this paper
• Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers.

  2012cited by this paper
• Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer

  2012cited by this paper
• Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.

  2012cited by this paper
• Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.

  2012cited by this paper
• Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

  2012cited by this paper
• Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.

  2011cited by this paper
• A Perspective on Cancer Cell Metastasis

  2011cited by this paper
• Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation

  2011cited by this paper
• Adropin Is a Novel Regulator of Endothelial Function

  2010cited by this paper
• Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition

  2010cited by this paper
• An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer

  2010cited by this paper
• Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation

  2010cited by this paper
• Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.

  2010cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• BMC Medical Genomics BioMed Central

  2008cited by this paper
• Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.

  2008cited by this paper
• G-protein-coupled receptors and cancer

  2007cited by this paper
• Mesenchymal to Epithelial Transition in Development and Disease

  2007cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

  2005cited by this paper
• Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways

  2005cited by this paper
• The orphan G-protein-coupled receptor GPR19 is expressed predominantly in neuronal cells during mouse embryogenesis

  2004cited by this paper
• Identification of Signal Transduction Pathways Used by Orphan G Protein-Coupled Receptors

  2003cited by this paper
• The G protein-coupled receptor repertoires of human and mouse

  2003cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Signaling from E-cadherins to the MAPK Pathway by the Recruitment and Activation of Epidermal Growth Factor Receptors upon Cell-Cell Contact Formation*

  2000cited by this paper
• The war on cancer.

  1996cited by this paper
• A novel gene codes for a putative G protein‐coupled receptor with an abundant expression in brain

  1996cited by this paper

• Histone lactatation-related genes GPR19 and SLC22A16 are important diagnostic markers and drug treatment targets for prostate cancer.

  2026cites this paper
• Class A Orphans in GtoPdb v.2025.4

  2025cites this paper
• Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

  2025cites this paper
• Expression of adropin in the reproductive organs of healthy female dogs and those with cystic endometrial hyperplasia, pyometra, and ovarian cysts.

  2025cites this paper
• G protein-coupled receptors (GPCRs) in cancer prognosis and therapeutics: A comprehensive review.

  2025cites this paper
• Polygenic risk score and prostate specific antigen predict death from prostate cancer in men with intermediate aggressive cancer.

  2025cites this paper
• A review on molecular mechanisms underlying the contribution of Tspan8 and CD151 tumor and host exosomes to tumor progression, hematopoiesis and angiogenesis

  2025cites this paper
• Regulatory roles of circular RNAs in Wnt and other oncogenic signaling pathways in breast cancer progression: a comprehensive review

  2025cites this paper
• Adropin mitigates reproductive and metabolic dysfunctions in streptozotocin induced hyperglycemic mouse.

  2025cites this paper
• The Role of ENHO in Pancreatic Adenocarcinoma: A Bioinformatics Approach

  2025cites this paper
• Unraveling Obesity and Multiple Myeloma: Insights from Epidemiology and Molecular Mechanisms

  2025cites this paper
• Class A Orphans in GtoPdb v.2025.1

  2025cites this paper
• Adropin: A Cardio-Metabolic Hormone in the Periphery, a Neurohormone in the Brain?

  2025cites this paper
• Fluorescence Assisted Investigation of ERK1/2 Signaling in the Regulation of ATG3 and ATG5 Under Glutamine and Glucose Deprivation in Breast Cancer Cells.

  2025cites this paper
• The levels of adropin and its therapeutic potential in diabetes.

  2025cites this paper
• The Use of Biologics for Targeting GPCRs in Metastatic Cancers

  2025cites this paper
• The dark sides of the GPCR tree ‐ research progress on understudied GPCRs

  2024cites this paper
• Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells by Activating ERK/MAPK Signaling Cascades

  2024cites this paper
• Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer

  2024cites this paper
• Description and functional validation of human enteroendocrine cell sensors

  2024cites this paper
• Adropin Is Expressed in Pancreatic Islet Cells and Reduces Glucagon Release in Diabetes Mellitus

  2024cites this paper
• Unveiling the multifaceted role of adropin in various diseases (Review)

  2024cites this paper
• SH003 Induces DR5-Mediated Caspase-Dependent Apoptosis of NSCLC Through Inhibition of AKT Survival Pathway

  2024cites this paper
• Adropin promotes testicular functions by modulating redox homeostasis in adult mouse

  2024cites this paper
• The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.

  2024cites this paper
• Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis

  2024cites this paper
• A Weibull mixture cure frailty model for high-dimensional covariates

  2024cites this paper
• Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes

  2023cites this paper
• Adropin, a novel hepatokine: localization and expression during postnatal development and its impact on testicular functions of pre-pubertal mice

  2023cites this paper
• Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma

  2023cites this paper
• High Level of Adropin Promotes the Progression of Pancreatic Ductal Adenocarcinoma.

  2023cites this paper
• Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment

  2023cites this paper
• Expression of G protein-coupled receptor GPR19 in normal and neoplastic human tissues

  2023cites this paper
• Low-dose adropin stimulates inflammasome activation of macrophage via mitochondrial ROS involved in colorectal cancer progression

  2023cites this paper
• Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders.

  2023cites this paper
• Ontogeny of adropin and its receptor expression during postnatal development and its pro-gonadal role in the ovary of pre-pubertal mouse.

  2023cites this paper
• Adropin may regulate corpus luteum formation and its function in adult mouse ovary

  2023cites this paper
• Hypermethylated GPR135 gene expression is a favorable independent prognostic factor in nasopharyngeal carcinoma

  2023cites this paper
• GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process

  2023cites this paper
• Circulating levels of adropin and diabetes: a systematic review and meta-analysis of observational studies

  2023cites this paper
• Protective Roles of Adropin in Neurological Disease.

  2023cites this paper
• The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer

  2023cites this paper
• Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process

  2022cites this paper
• Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway

  2022cites this paper
• The LINC00261/MiR105-5p/SELL axis is involved in dysfunction of B cell and is associated with overall survival in hepatocellular carcinoma

  2022cites this paper
• Crosstalk between the liver and kidney in diabetic nephropathy.

  2022cites this paper
• Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum

  2022cites this paper
• G-protein coupled receptor 19 (GPR19) knockout mice display sex-dependent metabolic dysfunction

  2022cites this paper
• Design, Synthesis of New Pyrazoles and Chromenes as ERK‐2 Inhibitors, Apoptosis inducers and Cell cycle interrupters Based on Thiophene‐Chalcone Scaffold

  2022cites this paper
• [Galectin-1 knockdown inhibits proliferation, migration, invasion and promotes apoptosis of lung adenocarcinoma cells in vitro].

  2022cites this paper
• Adropin and insulin resistance: Integration of endocrine, circadian, and stress signals regulating glucose metabolism

  2021cites this paper
• Circulating levels of adropin and overweight/obesity: a systematic review and meta-analysis of observational studies

  2021cites this paper
• Class A Orphans in GtoPdb v.2021.3

  2021cites this paper
• Pancreatic cancer and adaptive metabolism in a nutrient-deficient environment

  2021cites this paper
• Adropin

  2021cites this paper
• Role of Adropin in Cardiometabolic Disorders: From Pathophysiological Mechanisms to Therapeutic Target

  2021cites this paper
• ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer

  2021cites this paper
• Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis

  2021cites this paper
• Adropin expression correlates with age-related neuropathologies in the human brain and improves neuroinflammation and cognitive function in aging mice

  2021cites this paper
• Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging mice

  2021cites this paper
• New Peptides as Potential Players in the Crosstalk Between the Brain and Obesity, Metabolic and Cardiovascular Diseases

  2021cites this paper
• Gpr19 is a circadian clock-controlled orphan GPCR with a role in modulating free-running period and light resetting capacity of the circadian clock

  2021cites this paper
• Role of CNK1, Ephrin B1, GPR19 and SMURF1 in breast cancer early diagnosis, metastasis and drug resistance

  2021cites this paper
• Adropin Slightly Modulates Lipolysis, Lipogenesis and Expression of Adipokines but Not Glucose Uptake in Rodent Adipocytes

  2021cites this paper
• Molecular cloning and characterization of the novel adropin from tilapia (Oreochromis niloticus): Involvement in the control of food intake

  2021cites this paper
• The Role of Peptide Hormones Discovered in the 21st Century in the Regulation of Adipose Tissue Functions

  2021cites this paper
• Anticancer activities of dietary benzyl isothiocyanate: A comprehensive review.

  2021cites this paper
• Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer

  2021cites this paper
• Unraveling the Molecular Nexus between GPCRs, ERS, and EMT

  2021influential citation
• Identifying Receptors for Neuropeptides and Peptide Hormones: Challenges and Recent Progress.

  2021cites this paper
• Evaluation of Glucagon-like Peptide-1, Adropin, and Desnutrin Levels and Related Factors in Patients with Bipolar Disorder

  2021cites this paper
• A Pan-cancer analysis of GPR183 correlated with tumor immunity

  2020cites this paper
• Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment

  2020cites this paper
• Adropin stimulates proliferation but suppresses differentiation in rat primary brown preadipocytes.

  2020cites this paper
• Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction

  2020cites this paper
• Adropin inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation.

  2020cites this paper
• Adropin as A Fat-Burning Hormone with Multiple Functions—Review of a Decade of Research

  2020influential citation
• ERK/MAPK signalling pathway and tumorigenesis

  2020cites this paper
• Tackling the complexities of orphan GPCR ligand discovery with rationally assisted approaches

  2020cites this paper
• Class A Orphans (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• ADROPIN: A HEPATOKINE MODULATOR OF VASCULAR FUNCTION AND CARDIAC FUEL METABOLISM.

  2020cites this paper
• Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line

  2020cites this paper
• Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis

  2019cites this paper
• Sphingosine 1–phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells

  2019cites this paper
• Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Effects of adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes.

  2019cites this paper
• A new method bridging graph theory and residue co-evolutionary networks for specificity determinant positions detection

  2018cites this paper
• Adropin regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway

  2018cites this paper
• Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice

  2018cites this paper
• Tilapia adropin: the localization and regulation of growth hormone gene expression in pituitary cells

  2017cites this paper
• ADROPIN ACTS IN THE PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS TO INFLUENCE NEURONAL EXCITABILITY

  2017influential citation
• Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells

  2017cites this paper